Increased metal content in the TDP-43A315T transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Frontiers in Aging Neuroscience

Volumn 6, Issue FEB, 2014, Pages

  Dang, Theresa N T ^a   Lim, Nastasia K H ^a   Grubman, Alexandra ^a   Li, Qiao Xin ^a   Volitakis, Irene ^a   White, Anthony R ^a   Crouch, Peter J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Amyotrophic lateral sclerosis (ALS); Copper (Cu); Frontotemporal lobar degeneration (FTLD); Manganese (Mn); Neurodegenerative disease; TAR DNA binding protein 43 (TDP 43); Zinc (Zn)

Indexed keywords

ALUMINUM; CALCIUM; COPPER; IRON; MAGNESIUM ION; MANGANESE; PHOSPHORUS; POTASSIUM; SODIUM ION; TAR DNA BINDING PROTEIN; TITANIUM; ZINC;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; COGNITION; CONTROLLED STUDY; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HOMEOSTASIS; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; ROTAROD TEST; SPINAL CORD; TRANSGENIC MOUSE; WILD TYPE; Y-MAZE TEST;

EID: 84895788859     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00015     Document Type: Article

References (41)

1. Ayton, S., Lei, P., Duce, J. A., Wong, B. X., Sedjahtera, A., Adlard, P. A., et al. (2013). Ceruloplasmin dysfunction and therapeutic potential for parkinson disease. Ann. Neurol. 73, 554-559. doi: 10.1002/ana.23817
2. Badrick, A. C., and Jones, C. E. (2011). Reorganizing metals: the use of chelating compounds as potential therapies for metal-related neurodegenerative disease. Curr. Top. Med. Chem. 11, 543-552. doi: 10.2174/156802611794785181
3. Barnham, K. J., Masters, C. L., and Bush, A. I. (2004). Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3, 205-214. doi: 10.1038/nrd1330
4. Beckman, J. S., Estevez, A. G., Crow, J. P., and Barbeito, L. (2001). Superoxide dismutase and the death of motoneurons in ALS. Trends Neurosci. 24, S15-20. doi: 10.1016/S0166-2236(01)00004-2
5. Caragounis, A., Price, K. A., Soon, C. P., Filiz, G., Masters, C. L., Li, Q. X., et al. (2010). Zinc induces depletion and aggregation of endogenous TDP-43. Free Radic. Biol. Med. 48, 1152-1161. doi: 10.1016/j.freeradbiomed.2010.01.035
6. Chen-Plotkin, A. S., Lee, V. M., and Trojanowski, J. Q. (2010). TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol. 6, 211-220. doi: 10.1038/nrneurol.2010.18
7. Connor, J. R., Menzies, S. L., St Martin, S. M., and Mufson, E. J. (1992). A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J. Neurosci. Res. 31, 75-83. doi: 10.1002/jnr.490310111
8. Crouch, P. J., and Barnham, K. J. (2012). Therapeutic redistribution of metal ions to treat Alzheimer's disease. Acc. Chem. Res. 45, 1604-1611. doi: 10.1021/ar300074t
9. Crow, J. P., Sampson, J. B., Zhuang, Y., Thompson, J. A., and Beckman, J. S. (1997). Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69, 1936-1944. doi: 10.1046/j.1471-4159.1997.69051936.x
10. Deshmane, S. L., Kremlev, S., Amini, S., and Sawaya, B. E. (2009). Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 29, 313-326. doi: 10.1089/jir.2008.0027
11. Esmaeili, M. A., Panahi, M., Yadav, S., Hennings, L., and Kiaei, M. (2013). Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. Int. J. Exp. Pathol. 94, 56-64. doi: 10.1111/iep.12006
12. Estevez, A. G., Crow, J. P., Sampson, J. B., Reiter, C., Zhuang, Y., Richardson, G. J., et al. (1999). Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286, 2498-2500. doi: 10.1126/science.286.5449.2498
13. Galimberti, D., Venturelli, E., Fenoglio, C., Guidi, I., Villa, C., Bergamaschini, L., et al. (2008). Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration. J. Neurol. 255, 539-544. doi: 10.1007/s00415-008-0737-6
14. Guo, Y., Wang, Q., Zhang, K., An, T., Shi, P., Li, Z., et al. (2012). HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice. Brain Res. 1460, 88-95. doi: 10.1016/j.brainres.2012.04.003
15. Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., et al. (1994). Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772-1775. doi: 10.1126/science.8209258
16. Hare, D., Austin, C., and Doble, P. (2012). Quantification strategies for elemental imaging of biological samples using laser ablation-inductively coupled plasma-mass spectrometry. Analyst 137, 1527-1537. doi: 10.1039/c2an15792f
17. Hung, L. W., Villemagne, V. L., Cheng, L., Sherratt, N. A., Ayton, S., White, A. R., et al. (2012). The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease. J. Exp. Med. 209, 837-854. doi: 10.1084/jem.20112285
18. Kiaei, M., Bush, A. I., Morrison, B. M., Morrison, J. H., Cherny, R. A., Volitakis, I., et al. (2004). Genetically decreased spinal cord copper concentration prolongs life in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 24, 7945-7950. doi: 10.1523/jneurosci.2000-04.2004
19. Knopman, D. S., Petersen, R. C., Edland, S. D., Cha, R. H., and Rocca, W. A. (2004). The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 62, 506-508. doi: 10.1212/01.WNL.0000106827.39764.7E
20. Letiembre, M., Liu, Y., Walter, S., Hao, W., Pfander, T., Wrede, A., et al. (2009). Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurobiol. Aging 30, 759-768. doi: 10.1016/j.neurobiolaging.2007.08.018
21. Liscic, R. M., Grinberg, L. T., Zidar, J., Gitcho, M. A., and Cairns, N. J. (2008). ALS and FTLD: two faces of TDP-43 proteinopathy. Eur. J. Neurol. 15, 772-780. doi: 10.1111/j.1468-1331.2008.02195.x
22. Lomen-Hoerth, C., Anderson, T., and Miller, B. (2002). The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59, 1077-1079. doi: 10.1212/WNL.59.7.1077
23. Lothian, A., Hare, D. J., Grimm, R., Ryan, T. M., Masters, C. L., and Roberts, B. R. (2013). Metalloproteomics: principles, challenges and applications to neurodegeneration. Front. Aging Neurosci. 5:35. doi: 10.3389/fnagi.2013.00035
24. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. (1998). Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52. doi: 10.1016/S0022-510X(98)00092-6
25. Matusch, A., Depboylu, C., Palm, C., Wu, B., Hoglinger, G. U., Schafer, M. K., et al. (2010). Cerebral bioimaging of Cu, Fe, Zn, and Mn in the MPTP mouse model of Parkinson's disease using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). J. Am. Soc. Mass Spectrom. 21, 161-171. doi: 10.1016/j.jasms.2009.09.022
26. Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., White, A. R., Beyreuther, K., et al. (2002). Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J. Biol. Chem. 277, 44670-44676. doi: 10.1074/jbc. M204379200
27. Molina-Holgado, F., Hider, R. C., Gaeta, A., Williams, R., and Francis, P. (2007). Metals ions and neurodegeneration. Biometals 20, 639-654. doi: 10.1007/s10534-006-9033-z
28. Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133. doi: 10.1126/science.1134108
29. Niebroj-Dobosz, I., Dziewulska, D., and Kwiecinski, H. (2004). Oxidative damage to proteins in the spinal cord in amyotrophic lateral sclerosis (ALS). Folia Neuropathol. 42, 151-156.
30. Papadimitriou, D., Le Verche, V., Jacquier, A., Ikiz, B., Przedborski, S., and Re, D. B. (2010). Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol. Dis. 37, 493-502. doi: 10.1016/j.nbd.2009.10.005
31. Parker, S. J., Meyerowitz, J., James, J. L., Liddell, J. R., Nonaka, T., Hasegawa, M., et al. (2012). Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes. PLoS ONE 7:e42277. doi: 10.1371/journal.pone.0042277
32. Pickering-Brown, S. M. (2010). Review: recent progress in frontotemporal lobar degeneration. Neuropathol. Appl. Neurobiol. 36, 4-16. doi: 10.1111/j.1365-2990.2009.01045.x
33. Roberts, B. R., Tainer, J. A., Getzoff, E. D., Malencik, D. A., Anderson, S. R., Bomben, V. C., et al. (2007). Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS. J. Mol. Biol. 373, 877-890. doi: 10.1016/j.jmb.2007.07.043
34. Roos, P. M., Vesterberg, O., Syversen, T., Flaten, T. P., and Nordberg, M. (2013). Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Biol. Trace Elem. Res. 151, 159-170. doi: 10.1007/s12011-012-9547-x
35. Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., et al. (1988). Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural. Transm. 74, 199-205. doi: 10.1007/BF01244786
36. Soon, C. P., Donnelly, P. S., Turner, B. J., Hung, L. W., Crouch, P. J., Sherratt, N. A., et al. (2011). Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model. J. Biol. Chem. 286, 44035-44044. doi: 10.1074/jbc. M111.274407
37. Tamano, H., and Takeda, A. (2011). Dynamic action of neurometals at the synapse. Metallomics 3, 656-661. doi: 10.1039/c1mt00008j
38. Tokuda, E., Okawa, E., Watanabe, S., Ono, S. I., and Marklund, S. L. (2013). Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities. Neurobiol. Dis. 54, 308-319. doi: 10.1016/j.nbd.2013.01.001
39. Turner, B. J., Parkinson, N. J., Davies, K. E., and Talbot, K. (2009). Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model. Neurobiol. Dis. 34, 511-517. doi: 10.1016/j.nbd.2009.03.005
40. Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M., and Baloh, R. H. (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA 106, 18809-18814. doi: 10.1073/pnas.0908767106
41. Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., et al. (1995). An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116. doi: 10.1016/0896-6273(95)90259-7